AIFF vs BIO · rev $108.0K vs rev $2.58B
Firefly Neuroscience, Inc. (AIFF) versus BIO (BIO) — a side-by-side from cached financials, not a winner call.
Firefly Neuroscience, Inc. (AIFF) is a software - application company listed on US.
BIO (BIO) common stock.
Latest reported AIFF revenue for 2024-12-31 was $108.0K. Net income was -$10.5M. Revenue was down 78.3% from 2023-12-31 to 2024-12-31. AIFF currently screens at market cap $38.8M.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
AIFF currently screens at market cap $38.8M. BIO currently screens at market cap $0.
Not investment advice. Open the AIFF and BIO stock pages for the full models.
Not investment advice.